Dacron arterial grafts: the influence of porosity, velour, and maturity on thrombogenicity - PubMed (original) (raw)
- PMID: 6216621
Clinical Trial
Dacron arterial grafts: the influence of porosity, velour, and maturity on thrombogenicity
M Goldman et al. Surgery. 1982 Dec.
Abstract
It has been claimed that the neointimal healing of Dacron arterial prostheses can be enhanced by increasing porosity and including both an internal and an external velour layer. To test this, 24 patients received at random either woven (USCI, DeBakey, C. R. Bard, Inc.) or more porous, double-velour, knitted (Microvel, Meadox Medicals, Inc.) Dacron aortobifemoral prostheses. Graft thrombogenicity was measured using autogenous 111In-labeled platelets shortly following surgery and 6 to 9 months later. The thrombogenicity index was defined as the mean daily rise in the ratio of emissions over the graft to emissions over a reference area (aortic arch) and is a measure of platelet deposition. At early study the mean (+/- SE) thrombogenicity index was similar in woven and knitted graft patients at 0.19 +/- 0.4 and 0.14 +/- 0.2, respectively. In both groups it was lower (P less than 0.05) 6 to 9 months later at 0.06 +/- 0.2 (woven( and 0.08 +/- 0.1 (knitted), with again no difference between materials. Although platelet survival was restored to near normal values in both groups by 6 to 9 months, only one woven graft failed to demonstrate continued platelet accumulation by gamma-imaging. Thrombogenicity in Dacron grafts diminishes in the early months of maturation but is not affected by porosity and velour. Moreover, this thrombogenicity persists beyond the period of altered platelet survival.
Similar articles
- Indium 111-labeled platelet deposition in woven and knitted Dacron bifurcated aortic grafts with the same patient as a clinical model.
Robicsek F, Duncan GD, Anderson CE, Daugherty HK, Cook JW, Selle JG, Hess PJ, Easton EJ, Burtoft JN. Robicsek F, et al. J Vasc Surg. 1987 Jun;5(6):833-7. doi: 10.1067/mva.1987.avs0050833. J Vasc Surg. 1987. PMID: 2953910 - The influence of platelet-graft interaction on platelet survival in patients with aortobifemoral Dacron grafts.
Kotzé HF, Heyns AD, Nel CJ, Roodt JP, Herbst CP, Badenhorst PN, Lötter MG. Kotzé HF, et al. S Afr Med J. 1992 Jan 4;81(1):27-31. S Afr Med J. 1992. PMID: 1530891 - An experimental study of eight current arterial prostheses.
Mathisen SR, Wu HD, Sauvage LR, Usui Y, Walker MW. Mathisen SR, et al. J Vasc Surg. 1986 Jul;4(1):33-41. doi: 10.1067/mva.1986.avs0040033. J Vasc Surg. 1986. PMID: 2941595 - Late disruption of Dacron aortic grafts.
Wilson SE, Krug R, Mueller G, Wilson L. Wilson SE, et al. Ann Vasc Surg. 1997 Jul;11(4):383-6. doi: 10.1007/s100169900065. Ann Vasc Surg. 1997. PMID: 9236995 Review. - [Biodegradation of dacron vascular prostheses. Physico-chemical, histological, morphometric and ultrastructural study].
Tardito E, Biondo B, Caputo V, Freddi G, Grosso E, Mantero S, Motta A, Repetti ML, Tanzi MC, Matturri L. Tardito E, et al. Minerva Cardioangiol. 1993 Mar;41(3):59-80. Minerva Cardioangiol. 1993. PMID: 8510812 Review. Italian.
Cited by
- Bioprinting of Vascularized Tissue Scaffolds: Influence of Biopolymer, Cells, Growth Factors, and Gene Delivery.
Sarker MD, Naghieh S, Sharma NK, Ning L, Chen X. Sarker MD, et al. J Healthc Eng. 2019 Apr 2;2019:9156921. doi: 10.1155/2019/9156921. eCollection 2019. J Healthc Eng. 2019. PMID: 31065331 Free PMC article. Review. - Biomaterials for vascular tissue engineering.
Ravi S, Chaikof EL. Ravi S, et al. Regen Med. 2010 Jan;5(1):107-20. doi: 10.2217/rme.09.77. Regen Med. 2010. PMID: 20017698 Free PMC article. Review. - Polymeric materials for tissue engineering of arterial substitutes.
Ravi S, Qu Z, Chaikof EL. Ravi S, et al. Vascular. 2009 May-Jun;17 Suppl 1(Suppl 1):S45-54. doi: 10.2310/6670.2008.00084. Vascular. 2009. PMID: 19426609 Free PMC article. Review. - Tunable Elastomers with an Antithrombotic Component for Cardiovascular Applications.
Stahl AM, Yang YP. Stahl AM, et al. Adv Healthc Mater. 2018 Aug;7(16):e1800222. doi: 10.1002/adhm.201800222. Epub 2018 May 31. Adv Healthc Mater. 2018. PMID: 29855176 Free PMC article. - Highly porous drug-eluting structures: from wound dressings to stents and scaffolds for tissue regeneration.
Elsner JJ, Kraitzer A, Grinberg O, Zilberman M. Elsner JJ, et al. Biomatter. 2012 Oct-Dec;2(4):239-70. doi: 10.4161/biom.22838. Biomatter. 2012. PMID: 23507890 Free PMC article. Review.